FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290839887> ?p ?o ?g. }

• W4290839887 endingPage "e29711" @default.
• W4290839887 startingPage "e29711" @default.
• W4290839887 abstract "Tranexamic acid (TXA) reduces the risk of bleeding trauma death without altering the need for blood transfusion. We examined the effects of TXA on coagulation and fibrinolysis dynamics and the volume of transfusion during the early stage of trauma. This subanalysis of a prospective multicenter study of severe trauma included 276 patients divided into propensity score-matched groups with and without TXA administration. The effects of TXA on coagulation and fibrinolysis markers immediately at (time point 0) and 3 hours after (time point 3) arrival at the emergency department were investigated. The transfusion volume was determined at 24 hours after admission. TXA was administered to the patients within 3 hours (median, 64 minutes) after injury. Significant reductions in fibrin/fibrinogen degradation products and D-dimer levels from time points 0 to 3 in the TXA group compared with the non-TXA group were confirmed, with no marked differences noted in the 24-hour transfusion volumes between the 2 groups. Continuously increased levels of soluble fibrin, a marker of thrombin generation, from time points 0 to 3 and high levels of plasminogen activator inhibitor-1, a marker of inhibition of fibrinolysis, at time point 3 were observed in both groups. TXA inhibited fibrin(ogen)olysis during the early stage of severe trauma, although this was not associated with a reduction in the transfusion volume. Other confounders affecting the dynamics of fibrinolysis and transfusion requirement need to be clarified." @default.
• W4290839887 created "2022-08-12" @default.
• W4290839887 creator A5002108814 @default.
• W4290839887 creator A5009840963 @default.
• W4290839887 creator A5014991822 @default.
• W4290839887 creator A5016237045 @default.
• W4290839887 creator A5020423145 @default.
• W4290839887 creator A5027052805 @default.
• W4290839887 creator A5028226308 @default.
• W4290839887 creator A5033990548 @default.
• W4290839887 creator A5039878364 @default.
• W4290839887 creator A5042271407 @default.
• W4290839887 creator A5048823828 @default.
• W4290839887 creator A5050533134 @default.
• W4290839887 creator A5054137967 @default.
• W4290839887 creator A5064970536 @default.
• W4290839887 creator A5065790953 @default.
• W4290839887 creator A5068452757 @default.
• W4290839887 creator A5075860098 @default.
• W4290839887 creator A5078623020 @default.
• W4290839887 creator A5081383438 @default.
• W4290839887 creator A5081788004 @default.
• W4290839887 creator A5084473249 @default.
• W4290839887 creator A5087022496 @default.
• W4290839887 creator A5089292835 @default.
• W4290839887 creator A5091170116 @default.
• W4290839887 date "2022-08-12" @default.
• W4290839887 modified "2023-10-10" @default.
• W4290839887 title "Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score–matched analysis" @default.
• W4290839887 cites W1510329186 @default.
• W4290839887 cites W166426311 @default.
• W4290839887 cites W1845161206 @default.
• W4290839887 cites W1974873560 @default.
• W4290839887 cites W1987604733 @default.
• W4290839887 cites W1991297902 @default.
• W4290839887 cites W2010667344 @default.
• W4290839887 cites W2024773717 @default.
• W4290839887 cites W2063423624 @default.
• W4290839887 cites W2066352637 @default.
• W4290839887 cites W2146263509 @default.
• W4290839887 cites W2162132892 @default.
• W4290839887 cites W2162249417 @default.
• W4290839887 cites W2324437595 @default.
• W4290839887 cites W2333723951 @default.
• W4290839887 cites W2901832804 @default.
• W4290839887 cites W2946701161 @default.
• W4290839887 cites W2956716141 @default.
• W4290839887 cites W3006920632 @default.
• W4290839887 cites W3028808861 @default.
• W4290839887 cites W3132817925 @default.
• W4290839887 cites W3152983776 @default.
• W4290839887 doi "https://doi.org/10.1097/md.0000000000029711" @default.
• W4290839887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35960088" @default.
• W4290839887 hasPublicationYear "2022" @default.
• W4290839887 type Work @default.
• W4290839887 citedByCount "1" @default.
• W4290839887 crossrefType "journal-article" @default.
• W4290839887 hasAuthorship W4290839887A5002108814 @default.
• W4290839887 hasAuthorship W4290839887A5009840963 @default.
• W4290839887 hasAuthorship W4290839887A5014991822 @default.
• W4290839887 hasAuthorship W4290839887A5016237045 @default.
• W4290839887 hasAuthorship W4290839887A5020423145 @default.
• W4290839887 hasAuthorship W4290839887A5027052805 @default.
• W4290839887 hasAuthorship W4290839887A5028226308 @default.
• W4290839887 hasAuthorship W4290839887A5033990548 @default.
• W4290839887 hasAuthorship W4290839887A5039878364 @default.
• W4290839887 hasAuthorship W4290839887A5042271407 @default.
• W4290839887 hasAuthorship W4290839887A5048823828 @default.
• W4290839887 hasAuthorship W4290839887A5050533134 @default.
• W4290839887 hasAuthorship W4290839887A5054137967 @default.
• W4290839887 hasAuthorship W4290839887A5064970536 @default.
• W4290839887 hasAuthorship W4290839887A5065790953 @default.
• W4290839887 hasAuthorship W4290839887A5068452757 @default.
• W4290839887 hasAuthorship W4290839887A5075860098 @default.
• W4290839887 hasAuthorship W4290839887A5078623020 @default.
• W4290839887 hasAuthorship W4290839887A5081383438 @default.
• W4290839887 hasAuthorship W4290839887A5081788004 @default.
• W4290839887 hasAuthorship W4290839887A5084473249 @default.
• W4290839887 hasAuthorship W4290839887A5087022496 @default.
• W4290839887 hasAuthorship W4290839887A5089292835 @default.
• W4290839887 hasAuthorship W4290839887A5091170116 @default.
• W4290839887 hasBestOaLocation W42908398871 @default.
• W4290839887 hasConcept C126322002 @default.
• W4290839887 hasConcept C141071460 @default.
• W4290839887 hasConcept C168563851 @default.
• W4290839887 hasConcept C17923572 @default.
• W4290839887 hasConcept C203014093 @default.
• W4290839887 hasConcept C203092338 @default.
• W4290839887 hasConcept C2776825266 @default.
• W4290839887 hasConcept C2779036427 @default.
• W4290839887 hasConcept C2779637338 @default.
• W4290839887 hasConcept C2781436528 @default.
• W4290839887 hasConcept C2991743468 @default.
• W4290839887 hasConcept C42219234 @default.
• W4290839887 hasConcept C54173615 @default.
• W4290839887 hasConcept C71924100 @default.
• W4290839887 hasConceptScore W4290839887C126322002 @default.
• W4290839887 hasConceptScore W4290839887C141071460 @default.

• next